Use of gnrh antagonists in mammals to synchronize follicular wave emergence
US-2026034192-A1 · Feb 5, 2026 · US
Luteinising hormone-releasing hormone [LHRH]; Related peptides
Luteinising hormone-releasing hormone [LHRH]; Related peptides · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K7/23 |
| Official title | Luteinising hormone-releasing hormone [LHRH]; Related peptides |
| Display label | Luteinising hormone-releasing hormone [LHRH]; Related peptides |
| Total patents | 44 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 15 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Compositions and methods for treating a medical condition
US-2024301090-A1 · Sep 12, 2024 · US
Composition for treating cancer containing telomerase-targeting gnrh antagonist-derived peptide hs1002
US-2024247031-A1 · Jul 25, 2024 · US
METHODS AND COMPOSITIONS FOR VIRAL VECTORED GnRH VACCINES TO CONTROL REPRODUCTION AND BREEDING BEHAVIOR IN MAMMALS
US-2023136261-A1 · May 4, 2023 · US
Filamentous nanostructures and their use for treatment of pulmonary disease
US-2023127524-A1 · Apr 27, 2023 · US
Method for analyzing degarelix and associated products
US-2023024202-A1 · Jan 26, 2023 · US
Manufacture of degarelix
US-11510962-B2 · Nov 29, 2022 · US
Peptide derivatives and conjugates thereof for treating cancer
US-2022211860-A1 · Jul 7, 2022 · US
Amino deprotection using 3-(diethylamino)propylamine
US-2022185842-A1 · Jun 16, 2022 · US
Manufacture of Degarelix
US-11260102-B2 · Mar 1, 2022 · US
Manufacture of degarelix
US-2021138024-A1 · May 13, 2021 · US
Manufacture of degarelix
US-2021077564-A1 · Mar 18, 2021 · US
Manufacture of Degarelix
US-10765721-B2 · Sep 8, 2020 · US
Manufacture of degarelix
US-2019224271-A1 · Jul 25, 2019 · US
Manufacture of Degarelix
US-10172906-B2 · Jan 8, 2019 · US
Methods and compositions related to improving properties of pharmacological agents targeting nervous system
US-2018340012-A1 · Nov 29, 2018 · US
Curcumin conjugates for treating and preventing cancers
US-9937260-B2 · Apr 10, 2018 · US
Process for the manufacture of degarelix and its intermediates
US-9822146-B2 · Nov 21, 2017 · US
Manufacture of degarelix
US-2017319644-A1 · Nov 9, 2017 · US
Notch binding agents and antagonists and methods of use thereof
US-2017198031-A1 · Jul 13, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K7/23?
- CPC C07K7/23 is the Cooperative Patent Classification code for “Luteinising hormone-releasing hormone [LHRH]; Related peptides.”
- How many patents are filed under CPC C07K7/23 (Luteinising hormone-releasing hormone [LHRH]; Related peptides)?
- Our database includes 44 publications tagged with this CPC code.
- Is patent activity under CPC C07K7/23 growing?
- Publication counts under this code: 3 in 2023 vs 2 in 2024 (latest complete years).